SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is trending as record Super Bowl betting volume is anticipated, with community discussion intensely focused on how burgeoning prediction markets, operating under different regulatory frameworks, will impact its future profitability and market share amidst its own expansion into the evolving sector ahead of its impending earnings report.

WorldFinancial

WorldFinancial (WLFI) is trending amid a U.S. House probe into a significant investment deal, fueling polarized community discussion over its legitimacy as a Trump-linked project with ambitions in stablecoins and Real World Asset tokenization.

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

Cleveland-Cliffs is trending as investors await its upcoming earnings report and the highly anticipated, yet debated, POSCO partnership, with community sentiment split between expectations of a significant upside from strong HRC prices and the termination of a costly slab contract, versus concerns over recent equity dilution and historical underperformance within the steel sector.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is trending as the community hotly debates the implications of the company's abrupt halt of its compounded weight-loss pill due to intense regulatory scrutiny, with bulls anticipating a short squeeze now that legal overhang is removed and bears expressing deep concern over management's decision-making and potential impact on growth.

Walmart, Inc. engages in the retail and wholesale business. The company offers an assortment of merchandise and services at everyday low prices. It operates through the following business segments: Walmart U.S., Walmart International, and Sam's Club. The Walmart U.S. segment operates as a mass merchandiser of consumer products, operating under the Walmart and Walmart Neighborhood Market brands, including walmart.com. The Walmart International segment includes operations of wholly-owned subsidiaries in Canada, Chile, China, and Africa, and majority-owned subsidiaries in India, as well as Mexico and Central America. The Sam's Club segment manages membership-only warehouse clubs and operates samsclub.com. The company was founded by Samuel Moore Walton and James Lawrence Walton on July 2, 1962 and is headquartered in Bentonville, AR.

Walmart Inc

Walmart is buzzing after hitting a $1 trillion market cap and joining the Nasdaq-100, with its strategic AI partnerships and expanding e-commerce driving a narrative of robust, tech-driven retail transformation that has the community actively discussing its surprising strength.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending as investors eagerly await its BLA resubmission in February, a key step validated by the FDA's request for the full HOPE-3 clinical study report without additional trials. This development reinforces confidence in its Duchenne muscular dystrophy therapy and promising exosome platform amidst discussions of institutional interest.

Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. It operates through the following segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment produces medical technologies and devices that are used to help improve healthcare delivery. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, instruments, and reagent systems to detect infectious diseases, healthcare-associated infections, and cancers. The BD Interventional segment offers vascular, urology, oncology, and surgical specialty products to hospitals, ambulatory surgery centers, individual healthcare professionals, extended care facilities, alternate site facilities, and patients via its Homecare business. The company was founded by Maxwell W. Becton and Fairleigh S. Dickinson in 1897 and is headquartered in Franklin Lakes, NJ.

Becton Dickinson & Co.

Becton, Dickinson And Co.

Becton Dickinson is trending as investors anticipate its Q1 earnings, with community discussions weighing expected declines against broad product demand and significant corporate actions like the pending Waters Corp. spin-off. Recent innovations in AI-driven flow cytometry, expanded biologics partnerships, and new medical device approvals are also driving conversation around the stock's current valuation and future growth.

Confluent, Inc. engages in creating a data infrastructure platform focused on data in motion. The firm provides application architecture engagement, multi data center, security and upgrade engagement, and Amazon web services cloud deployment services. Its products include Confluent Cloud, Confluent Platform, WarpStream BYOC, Connectors, Flink, Stream Governance, and Confluent Hub. The company was founded by Edward Jay Kreps, Neha Narkhede, and Jun Rao on September 1, 2014, and is headquartered in Mountain View, CA.

Confluent Inc - Ordinary Shares Class A

Confluent Inc

Confluent is trending due to speculation of a potential acquisition, with IBM being mentioned as a possible suitor, driving community discussion around buyout price and valuation. Community members are weighing in on the potential benefits of an acquisition versus Confluent remaining independent, alongside real-time data analytics and AI prospects. Recent earnings reports, analyst ratings, and unusual options activity contribute to the heightened interest in the stock.

Transocean Ltd. engages in the provision of offshore contract drilling services for oil and gas wells. It also owns and operates offshore drilling fleets such as ultra-deepwater, harsh environment, deepwater, and midwater rigs. The company was founded in 1953 and is headquartered in Steinhausen, Switzerland.

Transocean Ltd

Transocean (RIG) is seeing a surge in bullish sentiment driven by fresh, high-value offshore drilling contract awards and upward revisions to its earnings estimates, signaling a strong backlog and improved financial outlook. The community is actively discussing its sustained uptrend, deepwater drilling demand, and high short interest, anticipating significant price appreciation.

SSgA Active Trust - State Street Financial Select Sector SPDR ETF

Financial Select Sector SPDR Fund

The Financial Select Sector SPDR Fund ($XLF) is actively discussed following mixed reactions to bank earnings, with community members divided between signs of underlying sector strength and heightened concerns over consumer credit fragility and proposed regulatory changes.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Given Average Recommendation of "Hold" by Brokerages

Shares of Eton Pharmaceuticals, Inc. (NASDAQ:ETON - Get Free Report) have been given an average rating of "Hold" by the five ratings firms that are covering the firm, Marketbeat reports. One equities...

Eton Pharmaceuticals (NASDAQ:ETON) Upgraded at Zacks Research

Zacks Research raised shares of Eton Pharmaceuticals from a "strong sell" rating to a "hold" rating in a research report on Thursday...

Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Receives Average Rating of "Hold" from Brokerages

Eton Pharmaceuticals, Inc. (NASDAQ:ETON - Get Free Report) has been given a consensus recommendation of "Hold" by the five analysts that are covering the company, Marketbeat reports. Two equities...

Eton Pharmaceuticals (NASDAQ:ETON) Downgraded by Wall Street Zen to Hold

Wall Street Zen downgraded shares of Eton Pharmaceuticals from a "buy" rating to a "hold" rating in a research note on Saturday...

What is HC Wainwright's Estimate for ETON FY2025 Earnings?

Eton Pharmaceuticals, Inc. (NASDAQ:ETON - Free Report) - Investment analysts at HC Wainwright cut their FY2025 earnings per share estimates for Eton Pharmaceuticals in a research report issued on...

Q4 EPS Forecast for Eton Pharmaceuticals Lowered by Analyst

Eton Pharmaceuticals, Inc. (NASDAQ:ETON - Free Report) - Research analysts at HC Wainwright cut their Q4 2026 EPS estimates for Eton Pharmaceuticals in a note issued to investors on Tuesday, December...

Divisadero Street Capital Management LP Purchases New Holdings in Eton Pharmaceuticals, Inc. $ETON

Divisadero Street Capital Management LP acquired a new position in Eton Pharmaceuticals, Inc. (NASDAQ:ETON - Free Report) during the 2nd quarter, according to the company in its most recent Form 13F...

Geode Capital Management LLC Has $8.45 Million Stock Position in Eton Pharmaceuticals, Inc. $ETON

Geode Capital Management LLC increased its position in shares of Eton Pharmaceuticals, Inc. (NASDAQ:ETON - Free Report) by 98.8% in the 2nd quarter, according to the company in its most recent filing...

Diametric Capital LP Increases Stock Holdings in Eton Pharmaceuticals, Inc. $ETON

Diametric Capital LP lifted its position in shares of Eton Pharmaceuticals, Inc. (NASDAQ:ETON - Free Report) by 333.0% in the 2nd quarter, according to its most recent filing with the Securities...

Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Receives Consensus Rating of "Hold" from Analysts

Shares of Eton Pharmaceuticals, Inc. (NASDAQ:ETON - Get Free Report) have received a consensus recommendation of "Hold" from the five research firms that are presently covering the stock...

Eton Pharmaceuticals, Inc. engages in the development, acquisition, and commercialization of prescription drug products. Its products include Biorphen, Alaway Preservative Free, zonisamide oral suspension, topiramate oral suspension, lamotrigine for oral suspension, cysteine injection, and ephedrine ready-to-use injection. The company was founded in April 2017 and is headquartered in Deer Park, IL.

Eton Pharmaceuticals Inc

Up 5%

Down 5%

Markets are hovering near key levels, making the next 5% move especially important for sentiment. A breakout higher could reinforce the bull case, while a 5% drop may signal rising risk and tighter conditions. Which comes first?

What will be the S&amp;P 500’s next 5% move?

Stocktwits

What will be the S&P 500’s next 5% move?

ETON
Eton Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest ETON News

ETONEton Pharmaceuticals Inc